ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.
Shen M, Liu S, Toland A, Hsu EC, Hartono AB, Alabi BR, Aslan M, Nguyen HM, Sessions CJ, Nolley R, Shi C, Huang J, Brooks JD, Corey E, Stoyanova T.
Shen M, et al. Among authors: nguyen hm.
Br J Cancer. 2023 Nov;129(11):1818-1828. doi: 10.1038/s41416-023-02448-y. Epub 2023 Oct 5.
Br J Cancer. 2023.
PMID: 37798372
Free PMC article.